Cours Sorrento Therapeutics, Inc. Deutsche Boerse AG
Actions
8STN
US83587F2020
Recherche biotechnologique et médicale
CA 2021 | 52,9 M 48,55 M 47,3 M | CA 2022 | 62,84 M 57,67 M 56,18 M | Capitalisation | 411 M 378 M 368 M |
---|---|---|---|---|---|
Résultat net 2021 | -428 M -393 M -383 M | Résultat net 2022 | -573 M -526 M -512 M | VE / CA 2021 | 29,1 x |
Dette nette 2021 | 111 M 102 M 98,97 M | Dette nette 2022 | 84,53 M 77,57 M 75,57 M | VE / CA 2022 | 7,89 x |
PER 2021 |
-3,2
x | PER 2022 |
-0,65
x | Employés | 949 |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 97,77% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 01/01/89 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 03/03/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 01/04/12 |
David Lemus
BRD | Director/Board Member | 61 | 01/10/17 |
Jaisim Shah
BRD | Director/Board Member | 63 | 11/09/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
+20,17% | 127 Md | |
+24,67% | 117 Md | |
+25,44% | 27,67 Md | |
-17,74% | 20,33 Md | |
-15,17% | 16,79 Md | |
-15,21% | 15,63 Md | |
+11,91% | 14,84 Md | |
-47,10% | 14,65 Md | |
+54,50% | 14,43 Md |